Nutralife Biosciences Stock Today
| NLBS Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 66
|
Nutralife Biosciences is selling for under 1.0E-4 as of the 23rd of November 2024; that is No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. Nutralife Biosciences has more than 66 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Nutralife Biosciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of October 2023 and ending today, the 23rd of November 2024. Click here to learn more.
NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol products. NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida. The company has 176.62 M outstanding shares. More on Nutralife Biosciences
Moving against Nutralife Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Nutralife Pink Sheet Highlights
| President CEO, Director | Edgar Ward |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Nutralife Biosciences [NLBS] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.62 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nutralife Biosciences's market, we take the total number of its shares issued and multiply it by Nutralife Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Nutralife Biosciences conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 176.62 M outstanding shares.
Nutralife Biosciences currently holds about 51.8 K in cash with (487.39 K) of positive cash flow from operations.
Check Nutralife Biosciences Probability Of Bankruptcy
Ownership AllocationNutralife Biosciences maintains a total of 176.62 Million outstanding shares. Nutralife Biosciences holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Nutralife Ownership Details
Nutralife Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Nutralife Biosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Additional Tools for Nutralife Pink Sheet Analysis
When running Nutralife Biosciences' price analysis, check to measure Nutralife Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutralife Biosciences is operating at the current time. Most of Nutralife Biosciences' value examination focuses on studying past and present price action to predict the probability of Nutralife Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutralife Biosciences' price. Additionally, you may evaluate how the addition of Nutralife Biosciences to your portfolios can decrease your overall portfolio volatility.